Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) Peptide
PARK2
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN7236241
Quick Overview for Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2) Peptide (ABIN7236241)
Target
Parkin (PARK2)
(Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Purpose
- E3 Ubiquitin-Protein Ligase Parkin, Parkin RBR E3 ubiquitin-protein ligase, Parkinson Juvenile Disease Protein 2, PARK2, PRKN
-
Sequence
- Peptide (C)KELHHFRILG EEQYTR, correspond ing to amino acid residues 298 - 313 of mouse Parkin (Accession Q9WVS6).
-
Characteristics
- A Blocking peptide for Anti-Parkin Antibody (ABIN7237754).
-
Purity
- >70 %
-
-
-
-
Application Notes
- Antigen Preadsorption Control: 1 μg peptide per 1 μg antibody.
-
Comment
-
Confirmed by amino acid analysis and mass spectrometry.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- 100 μL double distilled water (DDW).
-
Concentration
- 0.4 mg/mL
-
Storage
- RT,-20 °C
-
Storage Comment
- Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
-
-
- Parkin (PARK2) (Parkinson Protein 2, E3 Ubiquitin Protein Ligase (Parkin) (PARK2))
Target
-
You are here:
